Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell lines

<em><strong>Objective(s):</strong></em> The growing trend of research demonstrates that dynamic expression of two metastasis repressor classes (metastasis suppressor genes and anti-metastatic miRNA) has a close relationship with tumor invasion and metastasis. Using different...

Full description

Bibliographic Details
Main Authors: Samila Farokhimanesh, Mehdi Forouzandeh Moghadam, Marzieh Ebrahimi
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2020-02-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
Online Access:http://ijbms.mums.ac.ir/article_14288_f3e7a762440d6352f0c5afff584f1725.pdf
_version_ 1811277807432499200
author Samila Farokhimanesh
Mehdi Forouzandeh Moghadam
Marzieh Ebrahimi
author_facet Samila Farokhimanesh
Mehdi Forouzandeh Moghadam
Marzieh Ebrahimi
author_sort Samila Farokhimanesh
collection DOAJ
description <em><strong>Objective(s):</strong></em> The growing trend of research demonstrates that dynamic expression of two metastasis repressor classes (metastasis suppressor genes and anti-metastatic miRNA) has a close relationship with tumor invasion and metastasis. Using different strategies, it was revealed that cellular levels of miR-31 and Breast cancer Metastasis Suppressor1 (BRMS1) protein, which are among the most significant modulators of metastasis, have a correlation with the cell’s capability for invading and metastasizing; cells containing higher levels of miR-31 or BRMS1 were less metastatic. This project was carried out to determine whether the combinations of miR-31 and BRMS1 genes are able to enhance the capability of repressing the claudin-low breast cancer cell (MDA-MB-231) invasion. Materials and <em><strong>Methods:</strong></em> This study used a restoration-based approach by miR-31 mimic and optimized BRMS1 gene sequences, which were cloned into a chimeric construct and transfected to the MDA-M231cells. <br /><em><strong>Results:</strong></em> Our data revealed that the simultaneous expression of anti-metastasis miR and metastasis suppressor might inhibit migration and invasion in MDA-MB-231 cells efficiently.<br /><em><strong>Conclusion:</strong></em> This combinatorial use of anti-metastatic miR and gene suggests a new therapeutic intervention for metastasis inhibition in MDA-MB-231.
first_indexed 2024-04-13T00:23:23Z
format Article
id doaj.art-52aad7ccdb6943e9bbc88ebafdaf18c3
institution Directory Open Access Journal
issn 2008-3866
2008-3874
language English
last_indexed 2024-04-13T00:23:23Z
publishDate 2020-02-01
publisher Mashhad University of Medical Sciences
record_format Article
series Iranian Journal of Basic Medical Sciences
spelling doaj.art-52aad7ccdb6943e9bbc88ebafdaf18c32022-12-22T03:10:41ZengMashhad University of Medical SciencesIranian Journal of Basic Medical Sciences2008-38662008-38742020-02-0123226427010.22038/ijbms.2019.35674.850014288Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell linesSamila Farokhimanesh0Mehdi Forouzandeh Moghadam1Marzieh Ebrahimi2Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran|Department of Biotechnology, Science and Research Branch, Islamic Azad Unversity, Tehran, IranDepartment of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IranDepartment of Stem Cells and Developmental Biology at Cell Science Research Center, Royan Institute for StemCell Biology and Technology, ACECR, Tehran, Iran<em><strong>Objective(s):</strong></em> The growing trend of research demonstrates that dynamic expression of two metastasis repressor classes (metastasis suppressor genes and anti-metastatic miRNA) has a close relationship with tumor invasion and metastasis. Using different strategies, it was revealed that cellular levels of miR-31 and Breast cancer Metastasis Suppressor1 (BRMS1) protein, which are among the most significant modulators of metastasis, have a correlation with the cell’s capability for invading and metastasizing; cells containing higher levels of miR-31 or BRMS1 were less metastatic. This project was carried out to determine whether the combinations of miR-31 and BRMS1 genes are able to enhance the capability of repressing the claudin-low breast cancer cell (MDA-MB-231) invasion. Materials and <em><strong>Methods:</strong></em> This study used a restoration-based approach by miR-31 mimic and optimized BRMS1 gene sequences, which were cloned into a chimeric construct and transfected to the MDA-M231cells. <br /><em><strong>Results:</strong></em> Our data revealed that the simultaneous expression of anti-metastasis miR and metastasis suppressor might inhibit migration and invasion in MDA-MB-231 cells efficiently.<br /><em><strong>Conclusion:</strong></em> This combinatorial use of anti-metastatic miR and gene suggests a new therapeutic intervention for metastasis inhibition in MDA-MB-231.http://ijbms.mums.ac.ir/article_14288_f3e7a762440d6352f0c5afff584f1725.pdfbreast cancerbrms1mir 31neoplasm metastasisreplacement therapy
spellingShingle Samila Farokhimanesh
Mehdi Forouzandeh Moghadam
Marzieh Ebrahimi
Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell lines
Iranian Journal of Basic Medical Sciences
breast cancer
brms1
mir 31
neoplasm metastasis
replacement therapy
title Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell lines
title_full Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell lines
title_fullStr Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell lines
title_full_unstemmed Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell lines
title_short Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell lines
title_sort metastasis inhibition by brms1 and mir 31 replacement therapy in claudin low cell lines
topic breast cancer
brms1
mir 31
neoplasm metastasis
replacement therapy
url http://ijbms.mums.ac.ir/article_14288_f3e7a762440d6352f0c5afff584f1725.pdf
work_keys_str_mv AT samilafarokhimanesh metastasisinhibitionbybrms1andmir31replacementtherapyinclaudinlowcelllines
AT mehdiforouzandehmoghadam metastasisinhibitionbybrms1andmir31replacementtherapyinclaudinlowcelllines
AT marziehebrahimi metastasisinhibitionbybrms1andmir31replacementtherapyinclaudinlowcelllines